Logo image of EXPO

EXPONENT INC (EXPO) Stock Fundamental Analysis

USA - NASDAQ:EXPO - US30214U1025 - Common Stock

68.56 USD
+0.37 (+0.54%)
Last: 11/20/2025, 3:38:50 PM
Fundamental Rating

6

Taking everything into account, EXPO scores 6 out of 10 in our fundamental rating. EXPO was compared to 87 industry peers in the Professional Services industry. EXPO gets an excellent profitability rating and is at the same time showing great financial health properties. EXPO is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

EXPO had positive earnings in the past year.
EXPO had a positive operating cash flow in the past year.
EXPO had positive earnings in each of the past 5 years.
EXPO had a positive operating cash flow in each of the past 5 years.
EXPO Yearly Net Income VS EBIT VS OCF VS FCFEXPO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M

1.2 Ratios

EXPO's Return On Assets of 13.54% is amongst the best of the industry. EXPO outperforms 89.66% of its industry peers.
EXPO has a Return On Equity of 24.04%. This is in the better half of the industry: EXPO outperforms 75.86% of its industry peers.
The Return On Invested Capital of EXPO (13.57%) is better than 75.86% of its industry peers.
The Average Return On Invested Capital over the past 3 years for EXPO is below the industry average of 22.56%.
The last Return On Invested Capital (13.57%) for EXPO is well below the 3 year average (18.56%), which needs to be investigated, but indicates that EXPO had better years and this may not be a problem.
Industry RankSector Rank
ROA 13.54%
ROE 24.04%
ROIC 13.57%
ROA(3y)15.66%
ROA(5y)15.2%
ROE(3y)28.66%
ROE(5y)26.61%
ROIC(3y)18.56%
ROIC(5y)16.83%
EXPO Yearly ROA, ROE, ROICEXPO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

EXPO's Profit Margin of 18.35% is amongst the best of the industry. EXPO outperforms 86.21% of its industry peers.
EXPO's Profit Margin has been stable in the last couple of years.
EXPO has a better Operating Margin (20.46%) than 87.36% of its industry peers.
In the last couple of years the Operating Margin of EXPO has remained more or less at the same level.
The Gross Margin of EXPO (92.62%) is better than 98.85% of its industry peers.
EXPO's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 20.46%
PM (TTM) 18.35%
GM 92.62%
OM growth 3Y-2.87%
OM growth 5Y0.97%
PM growth 3Y-3.48%
PM growth 5Y-0.25%
GM growth 3Y-0.15%
GM growth 5Y-0.21%
EXPO Yearly Profit, Operating, Gross MarginsEXPO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

9

2. Health

2.1 Basic Checks

EXPO has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
EXPO has more shares outstanding than it did 1 year ago.
EXPO has less shares outstanding than it did 5 years ago.
There is no outstanding debt for EXPO. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
EXPO Yearly Shares OutstandingEXPO Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
EXPO Yearly Total Debt VS Total AssetsEXPO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

EXPO has an Altman-Z score of 9.12. This indicates that EXPO is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 9.12, EXPO belongs to the top of the industry, outperforming 94.25% of the companies in the same industry.
There is no outstanding debt for EXPO. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 9.12
ROIC/WACC1.55
WACC8.76%
EXPO Yearly LT Debt VS Equity VS FCFEXPO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.3 Liquidity

EXPO has a Current Ratio of 3.15. This indicates that EXPO is financially healthy and has no problem in meeting its short term obligations.
EXPO has a Current ratio of 3.15. This is amongst the best in the industry. EXPO outperforms 87.36% of its industry peers.
EXPO has a Quick Ratio of 3.15. This indicates that EXPO is financially healthy and has no problem in meeting its short term obligations.
EXPO's Quick ratio of 3.15 is amongst the best of the industry. EXPO outperforms 88.51% of its industry peers.
Industry RankSector Rank
Current Ratio 3.15
Quick Ratio 3.15
EXPO Yearly Current Assets VS Current LiabilitesEXPO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

3

3. Growth

3.1 Past

The earnings per share for EXPO have decreased by -0.97% in the last year.
The Earnings Per Share has been growing slightly by 6.74% on average over the past years.
EXPO shows a small growth in Revenue. In the last year, the Revenue has grown by 4.90%.
The Revenue has been growing slightly by 6.01% on average over the past years.
EPS 1Y (TTM)-0.97%
EPS 3Y3.72%
EPS 5Y6.74%
EPS Q2Q%10%
Revenue 1Y (TTM)4.9%
Revenue growth 3Y6.2%
Revenue growth 5Y6.01%
Sales Q2Q%9.58%

3.2 Future

EXPO is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 5.06% yearly.
Based on estimates for the next years, EXPO will show a small growth in Revenue. The Revenue will grow by 6.32% on average per year.
EPS Next Y-1.05%
EPS Next 2Y3.58%
EPS Next 3Y5.06%
EPS Next 5YN/A
Revenue Next Year4.08%
Revenue Next 2Y5.99%
Revenue Next 3Y6.32%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
EXPO Yearly Revenue VS EstimatesEXPO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M
EXPO Yearly EPS VS EstimatesEXPO Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5 2

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 33.44, which means the current valuation is very expensive for EXPO.
Compared to the rest of the industry, the Price/Earnings ratio of EXPO is on the same level as its industry peers.
The average S&P500 Price/Earnings ratio is at 25.47. EXPO is valued slightly more expensive when compared to this.
Based on the Price/Forward Earnings ratio of 30.14, the valuation of EXPO can be described as expensive.
Based on the Price/Forward Earnings ratio, EXPO is valued a bit more expensive than the industry average as 60.92% of the companies are valued more cheaply.
EXPO's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 35.42.
Industry RankSector Rank
PE 33.44
Fwd PE 30.14
EXPO Price Earnings VS Forward Price EarningsEXPO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, EXPO is valued a bit more expensive than the industry average as 63.22% of the companies are valued more cheaply.
EXPO's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 28.63
EV/EBITDA 25.78
EXPO Per share dataEXPO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

The excellent profitability rating of EXPO may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)4.96
EPS Next 2Y3.58%
EPS Next 3Y5.06%

6

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 1.72%, EXPO has a reasonable but not impressive dividend return.
EXPO's Dividend Yield is rather good when compared to the industry average which is at 4.28. EXPO pays more dividend than 80.46% of the companies in the same industry.
Compared to the average S&P500 Dividend Yield of 2.44, EXPO is paying slightly less dividend.
Industry RankSector Rank
Dividend Yield 1.72%

5.2 History

The dividend of EXPO is nicely growing with an annual growth rate of 28.57%!
EXPO has been paying a dividend for at least 10 years, so it has a reliable track record.
EXPO has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)28.57%
Div Incr Years11
Div Non Decr Years11
EXPO Yearly Dividends per shareEXPO Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

EXPO pays out 58.36% of its income as dividend. This is a bit on the high side, but may be sustainable.
EXPO's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP58.36%
EPS Next 2Y3.58%
EPS Next 3Y5.06%
EXPO Yearly Income VS Free CF VS DividendEXPO Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
EXPO Dividend Payout.EXPO Dividend Payout, showing the Payout Ratio.EXPO Dividend Payout.PayoutRetained Earnings

EXPONENT INC

NASDAQ:EXPO (11/20/2025, 3:38:50 PM)

68.56

+0.37 (+0.54%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)10-30 2025-10-30/amc
Earnings (Next)02-04 2026-02-04/amc
Inst Owners98.32%
Inst Owner Change-3.4%
Ins Owners0.94%
Ins Owner Change0.05%
Market Cap3.46B
Revenue(TTM)571.36M
Net Income(TTM)102.84M
Analysts77.78
Price Target89.76 (30.92%)
Short Float %4.98%
Short Ratio5.99
Dividend
Industry RankSector Rank
Dividend Yield 1.72%
Yearly Dividend1.07
Dividend Growth(5Y)28.57%
DP58.36%
Div Incr Years11
Div Non Decr Years11
Ex-Date12-05 2025-12-05 (0.3)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)4.77%
Min EPS beat(2)3.34%
Max EPS beat(2)6.21%
EPS beat(4)4
Avg EPS beat(4)5.87%
Min EPS beat(4)2.12%
Max EPS beat(4)11.81%
EPS beat(8)6
Avg EPS beat(8)5.81%
EPS beat(12)8
Avg EPS beat(12)5.15%
EPS beat(16)12
Avg EPS beat(16)6.06%
Revenue beat(2)1
Avg Revenue beat(2)-0.18%
Min Revenue beat(2)-0.43%
Max Revenue beat(2)0.08%
Revenue beat(4)2
Avg Revenue beat(4)-0.35%
Min Revenue beat(4)-2.41%
Max Revenue beat(4)1.35%
Revenue beat(8)4
Avg Revenue beat(8)0.24%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)3.87%
EPS NY rev (3m)4.58%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0.96%
Revenue NY rev (3m)1.03%
Valuation
Industry RankSector Rank
PE 33.44
Fwd PE 30.14
P/S 6.18
P/FCF 28.63
P/OCF 26.79
P/B 8.09
P/tB 8.26
EV/EBITDA 25.78
EPS(TTM)2.05
EY2.99%
EPS(NY)2.27
Fwd EY3.32%
FCF(TTM)2.39
FCFY3.49%
OCF(TTM)2.56
OCFY3.73%
SpS11.1
BVpS8.47
TBVpS8.3
PEG (NY)N/A
PEG (5Y)4.96
Graham Number19.77
Profitability
Industry RankSector Rank
ROA 13.54%
ROE 24.04%
ROCE 18.37%
ROIC 13.57%
ROICexc 21.59%
ROICexgc 22.07%
OM 20.46%
PM (TTM) 18.35%
GM 92.62%
FCFM 21.57%
ROA(3y)15.66%
ROA(5y)15.2%
ROE(3y)28.66%
ROE(5y)26.61%
ROIC(3y)18.56%
ROIC(5y)16.83%
ROICexc(3y)30.54%
ROICexc(5y)30.82%
ROICexgc(3y)31.45%
ROICexgc(5y)31.86%
ROCE(3y)25.12%
ROCE(5y)22.78%
ROICexgc growth 3Y-10.75%
ROICexgc growth 5Y-4.18%
ROICexc growth 3Y-10.36%
ROICexc growth 5Y-3.84%
OM growth 3Y-2.87%
OM growth 5Y0.97%
PM growth 3Y-3.48%
PM growth 5Y-0.25%
GM growth 3Y-0.15%
GM growth 5Y-0.21%
F-Score6
Asset Turnover0.74
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 84.31%
Cap/Sales 1.49%
Interest Coverage 250
Cash Conversion 103.74%
Profit Quality 117.59%
Current Ratio 3.15
Quick Ratio 3.15
Altman-Z 9.12
F-Score6
WACC8.76%
ROIC/WACC1.55
Cap/Depr(3y)141.73%
Cap/Depr(5y)120.6%
Cap/Sales(3y)2.21%
Cap/Sales(5y)1.87%
Profit Quality(3y)105.59%
Profit Quality(5y)110.44%
High Growth Momentum
Growth
EPS 1Y (TTM)-0.97%
EPS 3Y3.72%
EPS 5Y6.74%
EPS Q2Q%10%
EPS Next Y-1.05%
EPS Next 2Y3.58%
EPS Next 3Y5.06%
EPS Next 5YN/A
Revenue 1Y (TTM)4.9%
Revenue growth 3Y6.2%
Revenue growth 5Y6.01%
Sales Q2Q%9.58%
Revenue Next Year4.08%
Revenue Next 2Y5.99%
Revenue Next 3Y6.32%
Revenue Next 5YN/A
EBIT growth 1Y-3.43%
EBIT growth 3Y3.15%
EBIT growth 5Y7.03%
EBIT Next Year27.12%
EBIT Next 3Y12.22%
EBIT Next 5YN/A
FCF growth 1Y39.65%
FCF growth 3Y5.33%
FCF growth 5Y10.11%
OCF growth 1Y24.49%
OCF growth 3Y5.08%
OCF growth 5Y5.99%

EXPONENT INC / EXPO FAQ

What is the fundamental rating for EXPO stock?

ChartMill assigns a fundamental rating of 6 / 10 to EXPO.


What is the valuation status for EXPO stock?

ChartMill assigns a valuation rating of 2 / 10 to EXPONENT INC (EXPO). This can be considered as Overvalued.


Can you provide the profitability details for EXPONENT INC?

EXPONENT INC (EXPO) has a profitability rating of 8 / 10.


Can you provide the PE and PB ratios for EXPO stock?

The Price/Earnings (PE) ratio for EXPONENT INC (EXPO) is 33.44 and the Price/Book (PB) ratio is 8.09.


Can you provide the dividend sustainability for EXPO stock?

The dividend rating of EXPONENT INC (EXPO) is 6 / 10 and the dividend payout ratio is 58.36%.